Effects of ketamine on the developing central nervous system
|Published in||Ideggyogyaszati Szemle. 2007, vol. 60, no. 3-4, p. 109-112|
|Abstract||Ketamine is a widely used drug in pediatric anesthesia practice, acting primarily through the blockade of the N-methyl-D-aspartate (NMDA) type of glutamate receptors. A growing body of laboratory evidence, accumulated during the past few years, suggests that this drug could have potential adverse effects on the developing central nervous system. The goal of this short review is to give a brief synopsis of experimental work indicating ketamine-induced developmental neurotoxicity as well as to discuss potential limitations concerning extrapolation of these studies to clinical practice.|
|Keywords||Anesthetics, Dissociative/ adverse effects — Animals — Brain/ drug effects/growth & development — Central Nervous System/ drug effects — Humans — Ketamine/ adverse effects — Neurotoxicity Syndromes/ etiology — Receptors, N-Methyl-D-Aspartate/ antagonists & inhibitors/metabolism|
This document has no fulltext available yet, but you can contact its author by using the form below.
|Research group||Progéniteurs neuronaux|